Page last updated: 2024-10-16
adenine and Encephalopathy, Hepatic
adenine has been researched along with Encephalopathy, Hepatic in 2 studies
Research Excerpts
Excerpt | Relevance | Reference |
"To evaluate the efficacy and safety of adefovir dipivoxil in treatment of decompensated liver cirrhosis patients with YMDD motif mutation during lamivudine therapy." | 7.73 | [Adefovir dipivoxil in treatment of decompensated liver cirrhosis patients with YMDD mutation]. ( Su, GG; Ying, MF; Zhao, NF; Zhou, Y, 2005) |
"To evaluate the efficacy and safety of adefovir dipivoxil in treatment of decompensated liver cirrhosis patients with YMDD motif mutation during lamivudine therapy." | 3.73 | [Adefovir dipivoxil in treatment of decompensated liver cirrhosis patients with YMDD mutation]. ( Su, GG; Ying, MF; Zhao, NF; Zhou, Y, 2005) |
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
Tseng, PL | 1 |
Lu, SN | 1 |
Tung, HD | 1 |
Wang, JH | 1 |
Changchien, CS | 1 |
Lee, CM | 1 |
Su, GG | 1 |
Zhao, NF | 1 |
Zhou, Y | 1 |
Ying, MF | 1 |
Clinical Trials (1)
Trial Overview
Trial | Phase | Enrollment | Study Type | Start Date | Status |
Entecavir for Patients With Decompensated HBV-Related Cirrhosis:a Prospective Randomized Controlled Trial[NCT00663182] | Phase 4 | 200 participants (Anticipated) | Interventional | 2008-01-31 | Enrolling by invitation |
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Trials
1 trial available for adenine and Encephalopathy, Hepatic
Other Studies
1 other study available for adenine and Encephalopathy, Hepatic